About AVT
Browse Articles
Customer Services
You are here:  > Home Page > Publications > Antiviral Therapy

Registration open

Early bird rates available for the 2014 meeting of the International Workshop on Co-morbidities and Adverse Drug Reactions in HIV.

Most popular article

Review of drug interactions with telaprevir and antiretrovirals

2014 Subscriptions available

Order the next volume of Antiviral Therapy today.

Editors-in-Chief: Douglas D Richman & Joep MA Lange

Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases (2012 ISI impact factor: 3.07).

The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.


♦ Immediate online publication
♦ A leading Editorial Board ensuring high-quality standards
♦ Worldwide readership
♦ Inclusion in major indexing and abstracting services
♦ No page charges

Recently published

Rimsky et al. report long-term resistance to rilpivirine in the ECHO/THRIVE Phase III trials. At 96 weeks, resistance patterns were consistent with 48-week data, and suggest most virological failures and resistance-associated mutations occur during the first year of treatment. Overall, the evidence demonstrates rilpivirine is non-inferior to existing therapies for HIV-infected, treatment-naive patients. Read more here.

The Editorial Office welcomes queries about publishing supplements within the journal. Please visit the Supplements page for more information.

  ISSN: 1359-6535 (print); 2040-2058 (online)

Copyright © Nucleus Global 2014. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.